From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement

Gastrointestinal stromal tumor: Current approaches and future directions in the treatment of advanced disease

Last Updated: Wednesday, May 21, 2025

The article reviews treatment for advanced gastrointestinal stromal tumors, covering current tyrosine kinase inhibitors (imatinib, sunitinib, regorafenib, ripretinib, avapritinib). It emphasizes individualized, mutation-guided strategies by multidisciplinary expert teams, and explores future next-generation inhibitors and combination therapies.

Hematology/Oncology Clinics of North America
Advertisement
News & Literature Highlights
Advertisement
Advertisement